AVASTIN Adverse Event: Malignant neoplasm progression
AVASTIN Adverse Event: Malignant neoplasm progression is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: AVASTIN; Product category: Drug; Primary reaction: Malignant neoplasm progression.
| Primary drug | AVASTIN |
|---|---|
| Product category | Drug |
| Primary reaction | Malignant neoplasm progression |
| All reactions | Malignant neoplasm progression; Drug ineffective; Convulsion; Oral candidiasis; Thermal burn |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Female |
| All drugs reported | AVASTIN; AVASTIN; AVASTIN; LOMUSTINE |
| Reporter country | CA |
| Reporter type | 1 |
| Report date | 20140313 |
| Report ID | 10005435 |
$299/mo
Try FDATracker →